Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.
It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.
The global Ophthalmic Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ophthalmic Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Ophthalmic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ophthalmic Drugs in these regions.
This research report categorizes the global Ophthalmic Drugs market by top players/brands, region, type and end user. This report also studies the global Ophthalmic Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
- Santen Pharmaceutical
- Valeant Pharmaceuticals
- Sun Pharmaceutical Industries
- Actavis Generics
- Regeneron Pharmaceuticals
- Johnson and Johnson
- Bausch and Lomb
Market size by Product
- By Class
- Anti-VEGF Agents
- By Disease
- Dry Eye
- Retinal Disorders
Market size by End User
Market size by Region
- North America
- United States
- South Korea
- Central & South America
- Rest of Central & South America
- Middle East & Africa
- GCC Countries
- South Africa
The study objectives of this report are:
- To study and analyze the global Ophthalmic Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
- To understand the structure of Ophthalmic Drugs market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Ophthalmic Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
- To project the value and sales volume of Ophthalmic Drugs submarkets, with respect to key regions.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ophthalmic Drugs are as follows:
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ophthalmic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of content
1 Study Coverage
1.1 Ophthalmic Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Ophthalmic Drugs Market Size Growth Rate by Product
1.4.3 Anti-VEGF Agents
1.5 Market by End User
1.5.1 Global Ophthalmic Drugs Market Size Growth Rate by End User
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Drugs Market Size
2.1.1 Global Ophthalmic Drugs Revenue 2014-2025
2.1.2 Global Ophthalmic Drugs Sales 2014-2025
2.2 Ophthalmic Drugs Growth Rate by Regions
2.2.1 Global Ophthalmic Drugs Sales by Regions
2.2.2 Global Ophthalmic Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Ophthalmic Drugs Sales by Manufacturers
3.1.1 Ophthalmic Drugs Sales by Manufacturers
3.1.2 Ophthalmic Drugs Sales Market Share by Manufacturers
3.1.3 Global Ophthalmic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Ophthalmic Drugs Revenue by Manufacturers
3.2.1 Ophthalmic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Ophthalmic Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Ophthalmic Drugs Price by Manufacturers
3.4 Ophthalmic Drugs Manufacturing Base D
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/